×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
LS01 Future Directions Based on Experience Developing Drugs to Treat Novel Coronavirus Infections
Session Chair(s)
Kanji Hirai, RPh
Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
MSD K.K., Japan
Speaker(s)
Hiroko Kawaguchi
Hiroko Kawaguchi
MSD Japan, Japan
Associate Director, Regulatory Affairs
Hirofumi Sone
Hirofumi Sone
Pfizer R&D Japan, Japan
Manager, Japan Regulatory Lead, Regulatory Affairs
Yuji Arakawa
Yuji Arakawa
Ministry of Health, Labour and Welfare (MHLW), Japan